©The Author(s) 2026.
World J Clin Oncol. Jan 24, 2026; 17(1): 113304
Published online Jan 24, 2026. doi: 10.5306/wjco.v17.i1.113304
Published online Jan 24, 2026. doi: 10.5306/wjco.v17.i1.113304
Figure 1 Distribution of clinical characteristics stratified by gender and survival status.
Survival status (survival vs death); age (< 65 years vs ≥ 65 years); Karnofsky Performance Status (70, 80, 90, 100); smoking history (no vs yes); alcohol history (no vs yes); tumor location (cervical, upper thoracic, middle thoracic, lower thoracic, abdominal); clinical stage (I, II, III, IV); radiotherapy dose (< 60 vs ≥ 60); chemotherapy (no vs yes). RT: Radiotherapy; KPS: Karnofsky Performance Status.
- Citation: Xiao L, Liu YD, Zhang X, Zhang SC, Lyu JH. Post-treatment triglyceride-glucose index as survival protective factors in patients with esophageal squamous cell carcinoma. World J Clin Oncol 2026; 17(1): 113304
- URL: https://www.wjgnet.com/2218-4333/full/v17/i1/113304.htm
- DOI: https://dx.doi.org/10.5306/wjco.v17.i1.113304